Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
17.15
-0.35 (-2.00%)
At close: Feb 2, 2026, 4:00 PM EST
17.13
-0.02 (-0.12%)
After-hours: Feb 2, 2026, 7:30 PM EST
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.17 billion as of February 2, 2026. Its market cap has decreased by -45.24% in one year.
Market Cap
3.17B
Enterprise Value
2.59B
1-Year Change
-45.24%
Ranking
Category
Stock Price
$17.15
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.17B, a decrease of -33.82%. That is a compound annual growth rate of -7.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.23B | -19.50% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 3.53B |
| Denali Therapeutics | 3.39B |
| Viking Therapeutics | 3.28B |
| Erasca | 3.25B |
| Xenon Pharmaceuticals | 3.17B |
| Viridian Therapeutics | 3.15B |
| Arcutis Biotherapeutics | 3.11B |
| Vera Therapeutics | 3.07B |